A new therapy for genetic hearing loss has just been approved by the Food and Drug Administration (FDA). The treatment, Otarmeni (lunsotogene parvec-cwha), is the first-ever dual adeno-associated ...
On April 23, the Food and Drug Administration approved the first-ever gene therapy for a rare, congenital form of deafness. The treatment’s maker, biotechnology company Regeneron, says it plans to ...
In a worldwide first, a one-and-done gene therapy has been approved to treat a form of hereditary deafness. Many of the ...
Children born deaf because of a rare condition can now take a drug to restore their hearing after a gene therapy was approved in the U.S., ushering in a new era for the treatment of an inherited form ...
Many people delay addressing hearing loss because they don't know what to expect from a hearing test. The uncertainty can feel overwhelming, especially when considering hearing aids for the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results